0000950170-24-079559.txt : 20240701
0000950170-24-079559.hdr.sgml : 20240701
20240701160007
ACCESSION NUMBER: 0000950170-24-079559
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240627
FILED AS OF DATE: 20240701
DATE AS OF CHANGE: 20240701
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: QUAY STEVEN C
CENTRAL INDEX KEY: 0001008227
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35610
FILM NUMBER: 241090415
MAIL ADDRESS:
STREET 1: 22026 20TH AVENUE S E
STREET 2: SUITE 102
CITY: BOTHELL
STATE: WA
ZIP: 98021
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ATOSSA THERAPEUTICS, INC.
CENTRAL INDEX KEY: 0001488039
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 264753208
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 107 SPRING STREET
CITY: SEATTLE
STATE: WA
ZIP: 98104
BUSINESS PHONE: 206.588.0256
MAIL ADDRESS:
STREET 1: 107 SPRING STREET
CITY: SEATTLE
STATE: WA
ZIP: 98104
FORMER COMPANY:
FORMER CONFORMED NAME: ATOSSA GENETICS INC
DATE OF NAME CHANGE: 20100325
4
1
ownership.xml
4
X0508
4
2024-06-27
0001488039
ATOSSA THERAPEUTICS, INC.
ATOS
0001008227
QUAY STEVEN C
C/O ATOSSA THERAPEUTICS, INC.,
107 SPRING STREET
SEATTLE
WA
98104
true
true
false
false
President & CEO
false
Stock Option (right to buy)
1.05
2024-06-27
4
A
false
1795100
0.00
A
2034-06-27
Common Stock
1795100
1795100
D
The options shall vest on a quarterly basis over 24 months following June 27, 2024, subject to the Reporting Person's continued service to the Issuer through each applicable vesting date. The options were issued at approximately 9:30 a.m. (ET) on June 27, 2024, with an exercise price of $1.05, representing the most recently reported closing stock price on June 26, 2024.
/s/ Steven C. Quay
2024-07-01